Detalhe da pesquisa
1.
Flotillin-2 regulates epidermal growth factor receptor activation, degradation by Cbl-mediated ubiquitination, and cancer growth.
J Biol Chem
; 299(1): 102766, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36470425
2.
A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma.
Oncologist
; 28(10): 919-e972, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279797
3.
Patients' perspectives on prenatal screening results that suggest maternal cancer: A qualitative analysis.
Prenat Diagn
; 43(9): 1101-1109, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37409892
4.
NF-κB Signaling Modulates miR-452-5p and miR-335-5p Expression to Functionally Decrease Epithelial Ovarian Cancer Progression in Tumor-Initiating Cells.
Int J Mol Sci
; 24(9)2023 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175530
5.
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment.
Gynecol Oncol
; 159(1): 88-94, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32747013
6.
Production of a cellular product consisting of monocytes stimulated with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for human use.
J Transl Med
; 17(1): 82, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871636
7.
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study.
Lancet Oncol
; 19(2): 207-215, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29361470
8.
A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer.
J Transl Med
; 16(1): 196, 2018 07 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30012146
9.
IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contexts.
BMC Cancer
; 18(1): 595, 2018 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29801480
10.
Clinical trials in gynecologic oncology: Past, present, and future.
Gynecol Oncol
; 148(2): 393-402, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29212614
11.
Pharmacodynamic markers and clinical results from the phase 2 study of the SMAC mimetic birinapant in women with relapsed platinum-resistant or -refractory epithelial ovarian cancer.
Cancer
; 122(4): 588-597, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26566079
12.
Identification of therapeutic targets applicable to clinical strategies in ovarian cancer.
BMC Cancer
; 16: 678, 2016 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27558154
13.
Characterization of ovarian cancer cell lines as in vivo models for preclinical studies.
Gynecol Oncol
; 142(2): 332-40, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27235858
14.
Topotecan synergizes with CHEK1 (CHK1) inhibitor to induce apoptosis in ovarian cancer cells.
BMC Cancer
; 15: 196, 2015 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25884494
15.
The ASTRO clinical practice guidelines in cervical cancer: Optimizing radiation therapy for improved outcomes.
Gynecol Oncol
; 159(3): 607-610, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32972783
16.
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Cancer Cell
; 12(2): 115-30, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17692804
17.
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort.
Mol Cell Proteomics
; 12(6): 1621-31, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23449826
18.
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cells.
Proc Natl Acad Sci U S A
; 109(52): E3659-67, 2012 Dec 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-23236152
19.
The small molecule NSC676914A is cytotoxic and differentially affects NFκB signaling in ovarian cancer cells and HEK293 cells.
Cancer Cell Int
; 14: 75, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25324692
20.
Dual-inhibition of NAMPT and PAK4 induces anti-tumor effects in 3D-spheroids model of platinum-resistant ovarian cancer.
Cancer Gene Ther
; 31(5): 721-735, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424218